NCT03697109 · BASELINE
Baseline characteristics
Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.
- denoms
- counts
- group Id
- BG000
- value
- 152
- units
- Participants
- groups
- description
- Patients will receive relacorilant increased sequentially from 100 mg once daily to a maximum dose of 400 mg once daily. Relacorilant: Relacorilant is supplied as 100 mg capsules for oral dosing.
- id
- BG000
- title
- Relacorilant (OL Phase)
- measures
- classes
- categories
- measurements
- group Id
- BG000
- spread
- 13.23
- value
- 50.4
- dispersion Type
- STANDARD_DEVIATION
- param Type
- MEAN
- title
- Age, Continuous
- unit Of Measure
- years
- classes
- categories
- measurements
- group Id
- BG000
- value
- 127
- title
- Female
- measurements
- group Id
- BG000
- value
- 25
- title
- Male
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Sex: Female, Male
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 28
- title
- Hispanic or Latino
- measurements
- group Id
- BG000
- value
- 123
- title
- Not Hispanic or Latino
- measurements
- group Id
- BG000
- value
- 1
- title
- Unknown or Not Reported
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Ethnicity (NIH/OMB)
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 0
- title
- American Indian or Alaska Native
- measurements
- group Id
- BG000
- value
- 0
- title
- Asian
- measurements
- group Id
- BG000
- value
- 1
- title
- Native Hawaiian or Other Pacific Islander
- measurements
- group Id
- BG000
- value
- 18
- title
- Black or African American
- measurements
- group Id
- BG000
- value
- 121
- title
- White
- measurements
- group Id
- BG000
- value
- 6
- title
- More than one race
- measurements
- group Id
- BG000
- value
- 6
- title
- Unknown or Not Reported
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Race (NIH/OMB)
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- spread
- 24.660
- value
- 93.77
- dispersion Type
- STANDARD_DEVIATION
- param Type
- MEAN
- title
- Body weight
- unit Of Measure
- kg
- classes
- categories
- measurements
- group Id
- BG000
- spread
- 32.675
- value
- 34.738
- dispersion Type
- STANDARD_DEVIATION
- param Type
- MEAN
- title
- Body Mass Index (BMI)
- unit Of Measure
- kg/m^2
- classes
- categories
- measurements
- group Id
- BG000
- spread
- 18.0355
- value
- 114.85
- dispersion Type
- STANDARD_DEVIATION
- param Type
- MEAN
- title
- Waist circumference
- unit Of Measure
- cm
- classes
- categories
- measurements
- group Id
- BG000
- value
- 31
- description
- HTN is defined as mean systolic blood pressure (SBP) ≥135 or ≤170 mm Hg and/or mean diastolic blood pressure (DBP) ≥85 to ≤110 mm Hg.
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Hypertension (HTN) only
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 50
- description
- DM is defined as fasting plasma glucose ≥126 mg/dL and/or oral glucose tolerance test plasma glucose ≥200 mg/dL or hemoglobin A1c (HbA1c) ≥6.5%. IGT is defined as plasma glucose ≥140 mg/dL and \<200 mg/dL on a 2-hour oral glucose tolerance test.
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Diabetes mellitus (DM) or impaired glucose tolerance (IGT) only
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 71
- description
- HTN and DM/IGT as previously defined.
- param Type
- COUNT_OF_PARTICIPANTS
- title
- HTN and DM/IGT
- unit Of Measure
- Participants
- population Description
- The analysis population was patients in the Intent-to-Treat (ITT) Population which included all enrolled patients who received at least 1 dose of study drug.
Complete source fields
- denoms
- counts
- group Id
- BG000
- value
- 152
- units
- Participants
- groups
- description
- Patients will receive relacorilant increased sequentially from 100 mg once daily to a maximum dose of 400 mg once daily. Relacorilant: Relacorilant is supplied as 100 mg capsules for oral dosing.
- id
- BG000
- title
- Relacorilant (OL Phase)
- measures
- classes
- categories
- measurements
- group Id
- BG000
- spread
- 13.23
- value
- 50.4
- dispersion Type
- STANDARD_DEVIATION
- param Type
- MEAN
- title
- Age, Continuous
- unit Of Measure
- years
- classes
- categories
- measurements
- group Id
- BG000
- value
- 127
- title
- Female
- measurements
- group Id
- BG000
- value
- 25
- title
- Male
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Sex: Female, Male
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 28
- title
- Hispanic or Latino
- measurements
- group Id
- BG000
- value
- 123
- title
- Not Hispanic or Latino
- measurements
- group Id
- BG000
- value
- 1
- title
- Unknown or Not Reported
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Ethnicity (NIH/OMB)
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 0
- title
- American Indian or Alaska Native
- measurements
- group Id
- BG000
- value
- 0
- title
- Asian
- measurements
- group Id
- BG000
- value
- 1
- title
- Native Hawaiian or Other Pacific Islander
- measurements
- group Id
- BG000
- value
- 18
- title
- Black or African American
- measurements
- group Id
- BG000
- value
- 121
- title
- White
- measurements
- group Id
- BG000
- value
- 6
- title
- More than one race
- measurements
- group Id
- BG000
- value
- 6
- title
- Unknown or Not Reported
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Race (NIH/OMB)
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- spread
- 24.660
- value
- 93.77
- dispersion Type
- STANDARD_DEVIATION
- param Type
- MEAN
- title
- Body weight
- unit Of Measure
- kg
- classes
- categories
- measurements
- group Id
- BG000
- spread
- 32.675
- value
- 34.738
- dispersion Type
- STANDARD_DEVIATION
- param Type
- MEAN
- title
- Body Mass Index (BMI)
- unit Of Measure
- kg/m^2
- classes
- categories
- measurements
- group Id
- BG000
- spread
- 18.0355
- value
- 114.85
- dispersion Type
- STANDARD_DEVIATION
- param Type
- MEAN
- title
- Waist circumference
- unit Of Measure
- cm
- classes
- categories
- measurements
- group Id
- BG000
- value
- 31
- description
- HTN is defined as mean systolic blood pressure (SBP) ≥135 or ≤170 mm Hg and/or mean diastolic blood pressure (DBP) ≥85 to ≤110 mm Hg.
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Hypertension (HTN) only
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 50
- description
- DM is defined as fasting plasma glucose ≥126 mg/dL and/or oral glucose tolerance test plasma glucose ≥200 mg/dL or hemoglobin A1c (HbA1c) ≥6.5%. IGT is defined as plasma glucose ≥140 mg/dL and \<200 mg/dL on a 2-hour oral glucose tolerance test.
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Diabetes mellitus (DM) or impaired glucose tolerance (IGT) only
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 71
- description
- HTN and DM/IGT as previously defined.
- param Type
- COUNT_OF_PARTICIPANTS
- title
- HTN and DM/IGT
- unit Of Measure
- Participants
- population Description
- The analysis population was patients in the Intent-to-Treat (ITT) Population which included all enrolled patients who received at least 1 dose of study drug.
Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f
Preserved source evidence · Not medical advice
Triangle